You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MIT-001

Showing 1 - 25 of 834
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heathly Subjects Trial in Seoul (Single subcutaneous administration and Blood collection, Single subcutaneous administration and

Recruiting
  • Heathly Subjects
  • Single subcutaneous administration and Blood collection
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University
Oct 5, 2022

Oral Mucositis, Lymphoma, Multiple Myeloma Trial in Seoul (MIT-001, normal saline)

Recruiting
  • Oral Mucositis
  • +3 more
  • MIT-001
  • normal saline
  • Seoul, Korea, Republic of
  • +1 more
Aug 9, 2022

Head and Neck Squamous Cell Carcinoma, Oral Mucositis Trial in Korea, Republic of, United States (MIT-001 plus CCRT)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Oral Mucositis
  • MIT-001 plus CCRT
  • Gilbert, Arizona
  • +14 more
Jan 27, 2022

MiT Family Translocation Renal Cell Carcinomas (IMCOR)

Not yet recruiting
  • Renal Carcinoma
  • Data collection
  • Bordeaux, France
  • +3 more
Jul 8, 2022

Mitral Regurgitation, Mitral Valve Disease Trial (MUNICH TRANSCATHETER MITRAL VALVE REPLACEMENT SYSTEM)

Not yet recruiting
  • Mitral Regurgitation
  • Mitral Valve Disease
  • MUNICH TRANSCATHETER MITRAL VALVE REPLACEMENT SYSTEM
  • (no location specified)
May 22, 2023

Muscular Dystrophy, Duchenne Trial in Worldwide

Active, not recruiting
  • Muscular Dystrophy, Duchenne
    • Linz, Austria
    • +70 more
    Aug 16, 2022

    Depression Trial in Boston (Guided Imagery and Mindfulness, Facilitated Discussion)

    Completed
    • Depression
    • Guided Imagery and Mindfulness
    • Facilitated Discussion
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 1, 2022

    Low Back Pain, Chronic Low-back Pain, Chronic Pain Trial (High intensity training, Moderate intensity training)

    Recruiting
    • Low Back Pain
    • +2 more
    • High intensity training
    • Moderate intensity training
    • Diepenbeek, Limburg, Belgium
      Hasselt University
    Oct 5, 2022

    CRS Trial in Zurich (1) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3)

    Recruiting
    • CRS
    • 1) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3
    • Zurich, Switzerland
      Zurich University Hospital
    May 16, 2022

    Premature Birth, Risk Trial in Sabadell, Girona (MIT-PB, movement imitation therapy for preterm.)

    Recruiting
    • Premature Birth
    • Risk
    • MIT-PB, movement imitation therapy for preterm.
    • Sabadell, Barcelona, Spain
    • +1 more
    Apr 10, 2022

    Family Caregivers Trial (Mentalizing Imagery Therapy and caregiver skills mobile application, Caregiver skills mobile

    Not yet recruiting
    • Family Caregivers
    • Mentalizing Imagery Therapy and caregiver skills mobile application
    • Caregiver skills mobile application
    • (no location specified)
    Apr 11, 2022

    Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))

    Completed
    • Safety
    • +2 more
    • RHN-001 (one tablet 750mg)
    • RHN-001 (750mg * 2 Tablets)
    • Karachi, Sindh, Pakistan
      Center for Bioequivalence Studies and clinical research (CBSCR),
    Apr 26, 2023

    Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

    Not yet recruiting
    • Acneiform Eruption Due to Chemical
    • +2 more
    • HT-001 2% Topical Gel
    • +3 more
    • (no location specified)
    Dec 3, 2022

    Advanced Solid Tumor Trial in Shanghai (B4T2-001 autologous CAR-T)

    Recruiting
    • Advanced Solid Tumor
    • B4T2-001 autologous CAR-T
    • Shanghai, China/Shanghai, China
    • +1 more
    Oct 3, 2023

    l Gene Editing Therapy for Cardiovascular Disease

    Not yet recruiting
    • Atherosclerotic Cardiovascular Disease
    • +2 more
      • Auckland, New Zealand
      • +2 more
      Oct 31, 2023

      Non-Hodgkin Lymphoma Trial (CC-122, Dexamethasone)

      Not yet recruiting
      • Non-Hodgkin Lymphoma
      • (no location specified)
      Jan 10, 2023

      Intimate Partner Violence Trial in Braga, Póvoa De Varzim (Psychological)

      Recruiting
      • Intimate Partner Violence
      • Psychological
      • Braga, None Selected, Portugal
      • +1 more
      Aug 1, 2022

      Meibomian Gland Dysfunction, Dry Eye Trial in Australia, Canada, New Zealand (AZR-MD-001 Low Dose, AZR-MD-001 Mid Dose,

      Completed
      • Meibomian Gland Dysfunction
      • Dry Eye
      • AZR-MD-001 Low Dose
      • +3 more
      • Chatswood, New South Wales, Australia
      • +29 more
      Nov 23, 2022

      Acute Cannabinoid Intoxication Trial in Leiden (ANEB-001, Placebo)

      Active, not recruiting
      • Acute Cannabinoid Intoxication
      • Leiden, ZH, Netherlands
        Centre for Human Drug Research (CHDR)
      Jan 31, 2023

      Cystinosis Trial (Cysteamine Bitartrate, N-Acetylcysteine Amide)

      Not yet recruiting
      • Cystinosis
      • Cysteamine Bitartrate
      • N-Acetylcysteine Amide
      • (no location specified)
      Aug 15, 2023

      Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

      Recruiting
      • Astrocytoma, Grade IV
      • +3 more
      • CYNK-001 systemic and Intra cavity administration
      • Duarte, California
      • +5 more
      Jan 20, 2023

      Vaccine-Preventable Diseases, Herpes Zoster Trial in Seoul, Seongnam-si (CVI-VZV-001, Shingrix)

      Recruiting
      • Vaccine-Preventable Diseases
      • Herpes Zoster
      • CVI-VZV-001
      • Shingrix
      • Seoul, Eunpyeong-gu, Korea, Republic of
      • +1 more
      Nov 20, 2023

      Bacterial Vaginosis Trial in Boston, Msunduzi Municipality (LC106, LC115, Placebo)

      Recruiting
      • Bacterial Vaginosis
      • Boston, Massachusetts
      • +1 more
      Nov 13, 2023

      Atopic Dermatitis Trial in Beijing (GD-iExo-001, normal saline)

      Recruiting
      • Atopic Dermatitis
      • Beijing, Beijing, China
        Chinese Academy of Medical Science & Peking Union Medical Colleg
      Jul 23, 2023

      Oral Mucositis Trial (RRx-001, Intensity Modulated Radiation Therapy (IMRT), Cisplatin for injection 100 mg/m2)

      Not yet recruiting
      • Oral Mucositis
      • (no location specified)
      Jul 31, 2023